Benchling Co-Founder and CEO Sajith Wickramasekara kicks off Benchtalk 2024 and highlights new feature announcements for this software platform that powers the biotech sector

blonca9
Oct 1, 2024
1 min read

He describes the three main areas of Benchling's new features: Scaling the wet lab, powering the dry lab, and creating an open platform through apps and more.

Brought to you by:

Recent Posts

See All

On its 10-year anniversary, Arcus Biosciences is taking its 4th molecule into pivotal studies. Co-Founder & CEO Terry Rosen talks HIF-2⍺, TIGIT, and CD73

Siren Biotechnology is using an online platform to raise up to $5 million from the public in a "community round" - it might be a new avenue of funding for biotech companies

Theravance Biopharma has a key pivotal trial readout scheduled for late '25 / early '26 in symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA)

Benchling Co-Founder and CEO Sajith Wickramasekara kicks off Benchtalk 2024 and highlights new feature announcements for this software platform that powers the biotech sector

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight